• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型利奈唑胺氮杂螺环类似物作为抗菌和抗结核药物的设计、合成及生物学评价

Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents.

作者信息

Gadekar Pradip K, Roychowdhury Abhijit, Kharkar Prashant S, Khedkar Vijay M, Arkile Manisha, Manek Hardik, Sarkar Dhiman, Sharma Rajiv, Vijayakumar V, Sarveswari S

机构信息

Department of Medicinal Chemistry, Piramal Enterprises Ltd., 1, Nirlon Complex, Goregaon (East), Mumbai, 400063, India.

Department of Pharmaceutical Chemistry, SPP School of Pharmacy and Technology Management, SVKM's NMIMS, V. L. Mehta Road, Vile Parle (West), Mumbai, 400 056, India.

出版信息

Eur J Med Chem. 2016 Oct 21;122:475-487. doi: 10.1016/j.ejmech.2016.07.001. Epub 2016 Jul 7.

DOI:10.1016/j.ejmech.2016.07.001
PMID:27423637
Abstract

The design, synthesis and antimicrobial evaluation of a novel series of azaspiro analogues of linezolid (1) have been described. Linezolid comprises of a morpholine ring which is known for its metabolism-related liabilities. Therefore, the key modification made in the linezolid structure was the replacement of morpholine moiety with its bioisostere, 2-oxa-6-azaspiro[3.3]heptane. Furthermore, the replacement of N-acetyl terminal of 1 with various aromatic or aliphatic functionalities was carried out. The title compounds were evaluated against a panel of Gram-positive and Gram-negative bacteria and Mycobacterium tuberculosis. Subsequent structure-activity relationship (SAR) studies identified several compounds with mixed antibacterial and antitubercular profiles. Compound 22 (IC50 0.72, 0.51, 0.88, 0.49 μg/mL for Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, respectively) exhibited similar antibacterial profile as 1. The N-acetyl derivative 18 was similar to 1 in antitubercular profile. Thus, the present study successfully demonstrated the use of azaspiro substructure in the medicinal chemistry of antibacterial and antitubercular agents.

摘要

已描述了一系列新型利奈唑胺(1)氮杂螺类似物的设计、合成及抗菌评估。利奈唑胺含有一个因其与代谢相关的缺陷而闻名的吗啉环。因此,在利奈唑胺结构中进行的关键修饰是用其生物电子等排体2-氧杂-6-氮杂螺[3.3]庚烷取代吗啉部分。此外,还进行了用各种芳香或脂肪族官能团取代1的N-乙酰基末端的操作。对标题化合物针对一组革兰氏阳性菌、革兰氏阴性菌和结核分枝杆菌进行了评估。随后的构效关系(SAR)研究确定了几种具有混合抗菌和抗结核活性的化合物。化合物22(对大肠杆菌、铜绿假单胞菌、金黄色葡萄球菌、枯草芽孢杆菌的IC50分别为0.72、0.51、0.88、0.49μg/mL)表现出与1相似的抗菌活性。N-乙酰基衍生物18在抗结核活性方面与1相似。因此,本研究成功证明了氮杂螺亚结构在抗菌和抗结核药物的药物化学中的应用。

相似文献

1
Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents.新型利奈唑胺氮杂螺环类似物作为抗菌和抗结核药物的设计、合成及生物学评价
Eur J Med Chem. 2016 Oct 21;122:475-487. doi: 10.1016/j.ejmech.2016.07.001. Epub 2016 Jul 7.
2
Synthesis and in vitro evaluation of the antitubercular and antibacterial activity of novel oxazolidinones bearing octahydrocyclopenta[c]pyrrol-2-yl moieties.含八氢环戊[c]吡咯-2-基部分的新型恶唑烷酮类化合物的抗结核和抗菌活性的合成及体外评价
Chem Pharm Bull (Tokyo). 2014;62(12):1214-24. doi: 10.1248/cpb.c14-00510. Epub 2014 Oct 9.
3
Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.新型双恶唑烷酮化合物作为潜在强效和选择性抗结核药物的发现。
Bioorg Med Chem Lett. 2014 Mar 15;24(6):1496-501. doi: 10.1016/j.bmcl.2014.02.025. Epub 2014 Feb 15.
4
Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.作为抗菌剂的螺嘧啶三酮恶唑烷酮衍生物的设计、合成及生物学评价
Bioorg Med Chem Lett. 2018 Apr 15;28(7):1198-1206. doi: 10.1016/j.bmcl.2018.02.055. Epub 2018 Mar 6.
5
Design and synthesis of spiro[indole-thiazolidine]spiro[indole-pyrans] as antimicrobial agents.设计和合成螺[吲哚-噻唑烷]螺[吲哚-吡喃]作为抗菌剂。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5465-9. doi: 10.1016/j.bmcl.2011.06.121. Epub 2011 Jul 2.
6
Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: a Michael addition approach.活性抗结核、细胞毒性和抗菌剂的简便合成:一种迈克尔加成方法。
Eur J Med Chem. 2005 Nov;40(11):1143-8. doi: 10.1016/j.ejmech.2005.06.004. Epub 2005 Jul 22.
7
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.新型螺环氧化吲哚并吡咯烷和螺环氧化吲哚并吡咯并噻唑衍生物作为潜在抗结核药物的设计
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4308-13. doi: 10.1016/j.bmcl.2015.07.069. Epub 2015 Jul 26.
8
Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.抗结核药物。第 8 部分:基于 5-硝基呋喃的 1,2,3-三唑的合成、抗菌和抗结核活性。
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6842-6. doi: 10.1016/j.bmcl.2013.10.010. Epub 2013 Oct 11.
9
Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation.吲哚稠合螺色烯作为潜在的抗结核药物:设计、合成和体外评价。
Mol Divers. 2021 Nov;25(4):2137-2148. doi: 10.1007/s11030-020-10108-z. Epub 2020 May 30.
10
Synthesis and biological activity of piperazine derivatives of phenothiazine.吩噻嗪哌嗪衍生物的合成及生物活性
Drug Res (Stuttg). 2015 Jan;65(1):5-8. doi: 10.1055/s-0033-1364001. Epub 2014 Jan 27.

引用本文的文献

1
Spirocyclic compounds: potential drug leads in the fight against .螺环化合物:对抗……的潜在药物先导物
Future Med Chem. 2025 Apr;17(7):819-837. doi: 10.1080/17568919.2025.2479413. Epub 2025 Mar 19.
2
Practical and Scalable Two-Step Process for 6-(2-Fluoro-4-nitrophenyl)-2-oxa-6-azaspiro[3.3]heptane: A Key Intermediate of the Potent Antibiotic Drug Candidate TBI-223.6-(2-氟-4-硝基苯基)-2-氧杂-6-氮杂螺[3.3]庚烷的实用且可扩展的两步合成方法:强效抗生素候选药物TBI-223的关键中间体
Org Process Res Dev. 2023 Jul 12;27(7):1390-1399. doi: 10.1021/acs.oprd.3c00148. eCollection 2023 Jul 21.
3
Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine.
新型含嘧啶取代哌嗪的 3-(5-氟吡啶-3-基)-2-恶唑烷酮衍生物的优化与抗菌评价。
Molecules. 2023 May 23;28(11):4267. doi: 10.3390/molecules28114267.
4
Oxazolidinones as versatile scaffolds in medicinal chemistry.恶唑烷酮类化合物作为药物化学中用途广泛的骨架。
RSC Med Chem. 2023 Feb 8;14(5):823-847. doi: 10.1039/d2md00415a. eCollection 2023 May 25.
5
Antibacterial Properties and Computational Insights of Potent Novel Linezolid-Based Oxazolidinones.强效新型基于利奈唑胺的恶唑烷酮类化合物的抗菌特性及计算分析
Pharmaceuticals (Basel). 2023 Mar 30;16(4):516. doi: 10.3390/ph16040516.
6
Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-Oxazolidinone Derivatives as Antibacterial Agents.3-(吡啶-3-基)-2-恶唑烷酮衍生物作为抗菌剂的合成及生物学评价
Front Chem. 2022 Jul 18;10:949813. doi: 10.3389/fchem.2022.949813. eCollection 2022.
7
1,2,3-Triazole-quinazolin-4(3)-one conjugates: evolution of ergosterol inhibitor as anticandidal agent.1,2,3-三唑-喹唑啉-4(3)-酮缀合物:作为抗念珠菌剂的麦角甾醇抑制剂的演变
RSC Adv. 2018 Nov 27;8(69):39611-39625. doi: 10.1039/c8ra08426b. eCollection 2018 Nov 23.
8
Design, Synthesis, and the Effects of ()-9-Oxooctadec-10-en-12-ynoic Acid Analogues to Promote Glucose Uptake.促进葡萄糖摄取的()-9-氧代十八碳-10-烯-12-炔酸类似物的设计、合成及其效果
ACS Omega. 2021 Sep 9;6(37):24118-24127. doi: 10.1021/acsomega.1c03600. eCollection 2021 Sep 21.
9
Pd-catalyzed arylation of linear and angular spirodiamine salts under aerobic conditions.钯催化的线性和角型螺二胺盐在有氧条件下的芳基化反应。
Tetrahedron Lett. 2017 Feb 1;58(5):466-469. doi: 10.1016/j.tetlet.2016.12.063. Epub 2016 Dec 23.
10
Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a log Lowering Twist.通过添加碳降低亲脂性:氮杂螺庚烷,一种对数降低的扭转。
ACS Med Chem Lett. 2019 Jul 18;10(8):1198-1204. doi: 10.1021/acsmedchemlett.9b00248. eCollection 2019 Aug 8.